ED after prostate surgery: the honest map of restorative options
This is a composite decision situation, not a real patient, testimonial or individual treatment recommendation.
The cancer is out — that was the point, and it worked. What the consent form called “erectile dysfunction risk” turned out to mean daily reality. Pills help partially or not at all, and clinic ads promise “regenerative” fixes: shockwave, PRP, stem cells. This corner of men's health runs thick with confident marketing.
What the data says for this situation
Cell research here is real but early: 23 MSC studies (5 recruiting) in our snapshot, several specifically in post-prostatectomy ED, where small trials report improved erectile scores in some participants — open-label, small, unreplicated at scale. Nothing is approved. The adjacent market (shockwave, “P-shots”) shares the pattern: encouraging pilot data for shockwave in vascular ED, weak-to-absent evidence for PRP injections. Post-surgical ED is nerve-injury biology, distinct from vascular ED — many cited studies do not match the mechanism being sold.
Questions worth asking any provider
- Does the cited study cover post-prostatectomy (nerve-related) ED specifically?
- What IIEF score change was published, versus placebo or not?
- Where does this fit against established rehab (PDE5, devices, implant timeline)?
- Urologist oversight or clinic-only?
Red flags specific to this situation
- Vascular-ED study data sold for post-surgical cases
- Percentage success claims from open-label pilots
- Packages bundling PRP+shockwave+cells to obscure what did what
Cost context
Regenerative ED packages run €3,000–€12,000 abroad. Established management — through implants at the definitive end — has decades of outcome data urologists can walk you through.
FAQ
Can stem cells cure ED after prostatectomy?
Small early trials report improvements for some men; nothing controlled at scale, nothing approved.
Is penile shockwave therapy proven?
Pilot-level evidence exists for vascular ED; post-surgical nerve-injury ED is a different mechanism with weaker support.
→ Build questions for a specific provider · → Cost calculator
Interactive/editorial page by the StemCellAtlas research team. Where registry or literature counts appear, they use the dated 2026-08-29 snapshot. Browser-only tools do not send or store answers. Page generated 2026-08-29. See our editorial standards.